My research is placed in the cross field of oncology and molecular medicine. We correlate advanced molecular analyses of cancer tissues with extensive long-term follow-up. By doing this, we try to create new, precise ways of identifying the aggressiveness of the cancers, identifying both prognostic and predictive markers.
My research is furthermore focused on clinical trials, where I am PI on the NORDIC SUN trial, among others.
In the clinique, I work as a kidney cancer specialist, leading the treatment of metastatic kidney cancer at Aarhus University Hospital.